U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   Form 10-QSB

[X]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934
        For the quarterly period ended June 30, 2004

[ ]     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
        For the transition period from _________ to __________

Commission file number 33-17387

                          ALLIANCE HEALTH, INC.
   (Exact name of small business issuer as specified in its charter)

        Delaware                                   75-2192377
(State or other jurisdiction of         (IRS Employer Identification
 incorporation or organization)                      No.)


              421 E. Airport Freeway, Irving, Texas 75062
                (Address of principal executive office)

                            (972)-255-5533
                      (Issuer's telephone number)
       ------------------------------------------------------------
          (Former name, former address and former fiscal year,
                      if changed since last year)

Check whether issuer (1) filed all reports required to be filed by Section 13 or
15(d) of the Exchange Act during the past 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.
                           Yes   X    No


                  APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: At June 30, 2003, 1,534,066 shares of
common stock, $0.01 par value, were outstanding.

Transitional Small Business Disclosure Format (Check one):
     Yes      No    X



<page>


                              ALLIANCE HEALTH, INC.

                                      INDEX

                                   PAGE NUMBER

PART I    FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

    Independent Public Accounting Firm's Report                1

          Balance Sheets - June 30, 2004 (unaudited) and
            September 30, 2003 (audited)                       2

          Statements of Operations (unaudited) - Three
            Months and Nine Months Ended June 30, 2004
            and 2003                                           3

          Statements of Cash Flows (unaudited) - Nine
            Months Ended June 30, 2004 and 2003                4

          Notes to Financial Statements                       5-6

ITEM 2.   Management's Discussion and Analysis of
            Financial Condition and Results of
            Operations                                         7

ITEM 3.   Controls and Procedures                              8


PART II   OTHER INFORMATION

ITEM 6.   Exhibits and Reports on Form 8-K                     9

SIGNATURES                                                     10



<page>


                   INDEPENDENT PUBLIC ACCOUNTING FIRM'S REPORT





Board of Directors
Alliance Health, Inc.




We have reviewed the accompanying  balance sheet of Alliance Health,  Inc. as of
June 30, 2004, and the related  statements of operations for the three month and
nine month  periods  then ended.  These  interim  financial  statements  are the
responsibility of the Company's management.

We conducted our review in accordance  with standards  established by the Public
Company  Accounting  Oversight Board. A review of interim financial  information
consists  principally  of analytical  procedures  applied to financial  data and
making inquiries of persons responsible for financial and accounting matters. It
is  substantially  less in  scope  than an  audit in  accordance  with  auditing
standards   established  by  the  Public  Company  Accounting  Oversight  Board.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the  accompanying  financial  statements  in order  for them to be in
conformity with accounting principles generally accepted in the United States of
America.



                                                Whitley Penn


Dallas, Texas
August 12, 2004










<page>



                              ALLIANCE HEALTH, INC.

                                 BALANCE SHEETS



<TABLE>
<CAPTION>

                                                         June 30,  September 30,
                                                          2004          2003
                                                        --------  -------------
                                                       (Unaudited)   (Audited)
<S>                                                    <C>            <C>
Assets
Current assets:
      Cash and cash equivalents                        $   21,899     $  243,139
      Income taxes receivable                              17,485           --
      Treasury bills                                         --          500,000
                                                       ----------     ----------

Total assets                                           $   39,384     $  743,139
                                                       ==========     ==========


Liabilities and Stockholders' Equity
Current liabilities:
  Accounts payable                                     $     --       $      307
  Accrued liabilities                                       8,493          7,000
  Income taxes payable                                       --          164,800
                                                       ----------     ----------
Total current liabilities                                   8,493        172,107


Commitments and contingencies                                --             --

Stockholders' equity:
   Common stock, $.01 par, 20,000,000
     shares authorized, 14,360,000
     shares issued, 1,534,066 shares
     outstanding                                          143,600        143,600
   Paid-in capital                                        723,466        723,466
   Retained earnings                                    3,396,383      3,936,524
                                                       ----------     ----------
                                                        4,263,449      4,803,590

   Less 12,825,934 shares of stock
         held in treasury, at cost                      4,232,558      4,232,558
                                                       ----------     ----------
Total stockholders' equity                                 30,891        571,032
                                                       ----------     ----------

Total liabilities and stockholders' equity $               39,384     $  743,139
                                                       ==========     ==========
</TABLE>



                 See accompanying notes to financial statements.

                                       -2-

<page>

                              ALLIANCE HEALTH, INC.

                            STATEMENTS OF OPERATIONS

                                   (UNAUDITED)

<TABLE>
<CAPTION>


                                   Three Months Ended         Nine Months Ended
                                       June 30,                    June 30,
                                    2004         2003         2004        2003
                                  --------     --------     --------   ---------
<S>                                  <C>         <C>          <C>        <C>
Continuing Operations
Revenue                          $    --      $    --      $    --     $    --

General and administrative
    Expenses                         7,147       26,913       42,991     26,913

Other income:
   Interest income                    --          2,892          311      6,417

Income tax expense (benefit)        (2,716)      (9,128)     (16,337)    (7,789)
                                 ---------    ---------    ---------   ---------

Loss from continuing
  operations                        (4,431)     (14,893)     (26,343)   (12,707)

Discontinued Operations
  Income from discontinued
    Operations, net of $0,
    $282, $(38,466) and $5,722
    in income taxes,
    respectively                      --            760       38,466     15,438
  Gain on sale, net of $0, $0,
    $0 and $84,439 in income
    taxes, respectively               --           --           --      227,740

Net income (loss)                $  (4,431)   $ (14,133)   $  12,123  $ 230,471
                                 =========    =========     ========   =========

Basic and diluted earnings
 per share:

    Continuing operations            (0.00)       (0.01)       (0.02)     (0.00)

    Discontinued operations           --           0.00         0.03       0.07
                               -----------   ----------   ----------  ---------

    Net income (loss)          $     (0.00) $     (0.01) $      0.01 $     0.06
                                ==========   ==========   ==========  =========

Weighted average number
  of common shares
  outstanding                    1,534,066    1,534,066    1,534,066  3,642,150
                               ===========  ===========  =========== ==========
</TABLE>





                 See accompanying notes to financial statements.

                                       -3-


<page>

                              ALLIANCE HEALTH, INC.

                             STATEMENTS OF CASH FLOWS

                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                      Nine Months Ended
                                                June 30, 2004   June 30, 2003
                                                -----------------------------

<S>                                            <C>            <C>
Continuing operations:
Operating activities:
 Loss from continuing operations:              $   (26,343)   $   (12,707)
    Adjustments to reconcile loss
     from continuing operations to
     net cash provided by (used in)
     operating activities:
      Deferred income taxes                           --            8,612
      Changes in assets and liabilities:
       Income taxes receivable and payable        (182,285)       128,057
       Accounts payable                               (307)         2,410
       Accrued liabilities                           1,493        (51,999)
                                               -----------    -----------
Net cash provided by (used in) operating
 activities                                       (207,442)        74,373

Investing Activities:
 Proceeds from sales and maturities
  of treasury bills                                500,000      1,500,000
                                               -----------    -----------
Net cash provided by investing activities          500,000      1,500,000

Financing Activities:
 Purchases of treasury stock                          --       (2,142,558)
 Dividends paid                                   (552,264)          --
                                               -----------    -----------
Net cash used in financing activities             (552,264)    (2,142,558)

Discontinued operations:
 Operating activities                               38,466      1,995,013
 Investing activities                                 --          110,000
 Financing activities                                 --       (2,090,000)
                                               -----------    -----------
Net cash provided by discontinued operations        38,466         15,013
                                               -----------    -----------

Net decrease in cash                              (221,240)      (553,172)
Cash and cash equivalents at beginning
 of period                                         243,139        715,130
                                               -----------    -----------

Cash and cash equivalents at end of period     $    21,899    $   161,958
                                               ===========    ===========
</TABLE>

                 See accompanying notes to financial statements.


                                       -4-


<page>
                              ALLIANCE HEALTH, INC.

                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

Note 1.    Basis of Presentation

     The  accompanying  unaudited  financial  statements  have been  prepared in
accordance with accounting principles generally accepted in the United States of
America for interim  financial  information  and with the  instructions  to Form
10-QSB of  Regulation  S-B.  They do not include all  information  and footnotes
required by  accounting  principles  generally  accepted in the United States of
America for complete financial statements.  However, except as disclosed herein,
there has been no material change in the  information  disclosed in the notes to
the financial  statements for the year ended  September 30, 2003 included in the
Company's  Annual Report on Form 10-KSB filed with the  Securities  and Exchange
Commission.  The  interim  unaudited  financial  statements  should  be  read in
conjunction with those financial  statements included in the Form 10-KSB. In the
opinion  of  management,   all  adjustments  considered  necessary  for  a  fair
presentation, consisting solely of normal recurring adjustments, have been made.
Operating  results  for the  nine  month  period  ended  June  30,  2004 are not
necessarily  indicative  of the results that may be expected for the year ending
September 30, 2004.

Note 2.  Organization

     Alliance  Health,  Inc. (the  "Company")  was  incorporated  in Delaware on
September 4, 1987. The Company  previously  offered  advertising  and management
services to medical  clinics at affiliated  companies,  but the Company is now a
public shell as discussed  below under  discontinued  operations.  The Company's
corporate  offices  are  located  in  Irving,  Texas.  The  following  Directors
resigned:  George  Nicolaou,  M.D.  effective  May 21,  2004;  Mac  Martirossian
effective  August 10, 2004; James Kenney effective August 10, 2004 and Ken Guest
effective August 10, 2004. Dr. Kechejian is the only remaining Director.

Note 3.  Discontinued Operation

     During the year ended  September 30, 1999,  the Company  formed  Chiro-Med,
Inc. ("Chiro-Med"),  a wholly-owned  subsidiary.  Chiro-Med offered chiropractic
services.  Effective  February 29, 2000,  the Company  discontinued  Chiro-Med's
operations.  The Company  sold  Chiro-Med  to one of its  employees  for $27,593
during the year ended  September 30, 2001 through the issuance of a note at 6.3%
interest  maturing  on December 1, 2002.  The gain  connected  with the sale was
deferred and  recognized  as the Company  received  full  collection on the note
receivable during the year ended September 30, 2002.

     S.  J.  Kechejian,  M.D.,  P.A.  ("Principal  Stockholder")  cancelled  the
agreement with the Company for  advertising  and management  services  effective
August 31,  2002.  The Company had no  specific  business  plans at the time the
agreement  was  cancelled  and the Board of  Directors  elected  to  discontinue
operations  and  sell the  Company's  assets  to its  Principal  Stockholder  in
consideration  for $110,000 in cash and 6,333,333 shares of the Company's common
stock. In December 2002, the Company also purchased 4,955,875  additional shares
of the Company's common stock from the Company's  Principal  Stockholder and the
consideration  of  $1,635,439.  In March 2003, the Company  purchased  1,536,726
shares of the  Company's  common stock from  miscellaneous  stockholders  for an
aggregate  consideration of $507,119. All of these respective shares are held in
treasury stock.


                                       -5-

<page>
Note 4.  Dividend

     A  special  cash  dividend  of  $0.36  per  share,  totaling  $552,264  was
distributed to all stockholders of record on February 5, 2004.









                                       -6-
<page>
                              ALLIANCE HEALTH, INC.


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF INTERIM FINANCIAL INFORMATION

FORWARD LOOKING STATEMENT AND INFORMATION

     The Company is including  the following  cautionary  statement in this Form
10-QSB to make applicable and take advantage of the safe harbor provision of the
Private  Securities  Litigation  Reform  Act of  1995  for  any  forward-looking
statements  made by, or on behalf of, the  Company.  Forward-looking  statements
include  statements  concerning plans,  objectives,  goals,  strategies,  future
events or performance and underlying assumptions and other statements, which are
other than  statements  of  historical  facts.  Certain  statements in this Form
10-QSB are  forward-looking  statements.  Words such as  "expects,"  "believes,"
"anticipates,"  "may," and "estimates"  and similar  expressions are intended to
identify  forward-looking  statements.  Such statements are subject to risks and
uncertainties  that could cause actual results to differ  materially  from those
projected.  Such risks and  uncertainties  are set forth  below.  The  Company's
expectations,  beliefs  and  projections  are  expressed  in good  faith and are
believed  by  the  Company  to  have  a  reasonable  basis,   including  without
limitation,  management's  examination  of  historical  operating  trends,  data
contained in the Company's  records and other data available from third parties,
but  there  can  be no  assurance  that  management's  expectation,  beliefs  or
projections will result,  be achieved,  or be  accomplished.  The Company has no
obligation to update or revise these  forward-looking  statements to reflect the
occurrence of future events or circumstances.

     The  following  is   management's   discussion   and  analysis  of  certain
significant  factors which have affected the Company's  financial  condition and
results for the periods included in the accompanying financial statements.

Results of Operations and Financial Condition

     The financial  statements for the nine months ended June 30, 2003 have been
re-classified to reflect discontinued operations with applicable taxes.

     S.  J.  Kechejian,  M.D.,  P.A.,  Metroplex  Specialties,  P.A.  and  Metro
Pharmacy,  Inc.  notified  Alliance  Health,  Inc. of their  cancellation of the
ongoing fee arrangements for marketing effective August 31, 2002.

     Expenses  for the  three  months  ended  June 30,  2004  and 2003  included
salaries and employee benefits,  and other general and  administrative  costs in
the amount of $7,147 and $26,913, respectively. These same expenses for the nine
months ended June 30, 2004 and 2003 were $42,991 and $26,913 respectively. These
expenses were previously  categorized as discontinued  operations prior to April
1, 2003, but as the Company will now continue as a shell company,  these ongoing
expenses are classified as continuing operations.

     On October 28, 2002 the Board of  Directors  determined  it was in the best
interest of the Company to accept an offer from Dr.  Kechejian  to purchase  the
operating property and equipment of the Company in consideration of the transfer
back to the Company of 6,333,333 shares of Alliance common stock and $110,000 in
cash.  The sale of the assets to Dr.  Kechejian was  consummated on November 29,
2002. Simultaneous therewith,  Dr. Kechejian and entities that he controls, sold
back to the Company all of their remaining  shares of common stock, an aggregate
of  4,955,875  shares,  for a total cash  consideration  of  $1,635,439,  or the
audited book value per share as of September 30, 2002 of $0.33.


                                       -7-

<page>
     On March 15, 2003 the Company concluded its tender offer to purchase shares
for $0.33 per share  from its  stockholders.  The  Company  purchased  1,536,726
shares for $507,119. The Company has 1,534,066 shares of common stock issued and
outstanding after completion of the Offer.

     A  special  cash  dividend  of  $0.36  per  share,  totaling  $552,264  was
distributed to all shareholders of record on February 5, 2004.

     The Company is continuing to search for a suitable merger candidate.

Liquidity and Capital Resources

     The Company had cash of $21,899 at June 30, 2004.

Item 3.  Controls and Procedures

     (a)  Evaluation of disclosure controls and procedures.

          The  President/Treasurer/Director  of the  Company  has  conducted  an
          evaluation of the effectiveness of the Company's  disclosure  controls
          and procedures  pursuant to Rule 13a-14 under the Securities  Exchange
          Act of 1934 as of the last day of the period  covered  by this  report
          ("Evaluation  Date").  Based  upon  that  evaluation,  the  President/
          Treasurer/Director  concluded  that, as of the  Evaluation  Date,  the
          Company's   disclosure  controls  and  procedures  were  effective  in
          ensuring  that  all  material  information  relating  to  the  Company
          required to be filed in this  quarterly  report has been made known to
          him in a timely manner.

     (b)  Changes in internal controls.

          There have been no significant  changes made in the Company's internal
          controls or in other factors that could significantly  affect internal
          controls subsequent to the Evaluation Date.











                                       -8-
<page>

                              ALLIANCE HEALTH, INC.

                           PART II - OTHER INFORMATION

Items 1, 2, 3, 4 and 6 - Not applicable.

Item 6.  Exhibits and Reports on Form 8-K

     (a) Exhibits

          31.1 Certificate  of  Principal  Executive  Officer  required  by Rule
               13a-14(a)  or Rule  15d-14(a) of the  Securities  Exchange Act of
               1934,  as adopted  pursuant to Section 302 of the  Sarbanes-Oxley
               Act of 2002 (filed herewith).

          31.2 Certificate  of  Principal  Financial  Officer  required  by Rule
               13a-14(a)  or Rule  15d-14(a) of the  Securities  Exchange Act of
               1934,  as adopted  pursuant to Section 302 of the  Sarbanes-Oxley
               Act of 2002 (filed herewith). 32.1 Certificate of Chief Executive
               Officer  pursuant to 18 U.S.C.  Section 1350, as adopted pursuant
               to  Section  906  of  the   Sarbanes-Oxley  Act  of  2002  (filed
               herewith).  32.2 Certificate of Chief Financial  Officer pursuant
               to 18 U. S. C. Section 1350,  as adopted  pursuant to Section 906
               of the Sarbanes-Oxley Act of 2002 (filed herewith).

     (b) Reports on Form 8-K filed: None.







                                       -9-

<page>





                                   SIGNATURES


Pursuant  to the  requirements  of the  Section  13 or 15 (d) of the  Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.




DATED: August 12, 2004               By:  /s/Sarkis J. Kechejian, M.D.
                                          Sarkis J. Kechejian, M.D.
                                          President, Director and
                                          Treasurer











                                      -10-

<page>


                                                                   Exhibit 31.1

                                  CERTIFICATION


I, Sarkis J. Kechejian, M.D., certify that:

1. I have  reviewed  this  quarterly  report on Form 10-QSB of Alliance  Health,
Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such  disclosure  controls and procedures or caused such  disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared;

b) evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred  during the  registrant's  most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected,  or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's  Independent  Registered  Public  Accounting  Firm  and  the  audit
committee  of  registrant's  board  of  directors  (or  persons  performing  the
equivalent functions):

a) all  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

b) any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's  internal control over
financial reporting.

Date:  August 12, 2004

                                                /s/Sarkis J. Kechejian, M.D.
                                                Sarkis J. Kechejian, M.D.
                                                President and Treasurer
                                                Principal Executive Officer

<page>
                                                                   Exhibit 31.2

                                  CERTIFICATION

I, Sharilyn J. Bruntz Wilson, certify that:

1. I have  reviewed  this  quarterly  report on Form 10-QSB of Alliance  Health,
Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such  disclosure  controls and procedures or caused such  disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared;

b) evaluated  the  effectiveness  of the  registrant's  disclosure  controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

c) disclosed in this report any change in the registrant's internal control over
financial  reporting that occurred  during the  registrant's  most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected,  or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's  Independent  Registered  Public  Accounting  Firm  and  the  audit
committee  of  registrant's  board  of  directors  (or  persons  performing  the
equivalent functions):

a) all  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

b) any  fraud,  whether  or not  material,  that  involves  management  or other
employees who have a significant role in the registrant's  internal control over
financial reporting.


Date:  August 12, 2004


                                              /s/Sharilyn J. Bruntz Wilson
                                              Sharilyn J. Bruntz Wilson
                                              Vice President and Secretary
                                              Principal Financial Officer


<page>

                                                                   Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



By signing below, each of the undersigned  officers hereby certifies pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2003,  that,  to his  knowledge,  (i) this  report  fully  complies  with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and (ii) the  information  contained  in this  report  fairly  presents,  in all
material respects, the financial condition and results of operations of Alliance
Health, Inc.

Signed this 12th day of August, 2004.



/s/Sarkis J. Kechejian, M.D.
Sarkis J. Kechejian, M.D.
President, Director and Treasurer
Chief Executive Officer




<page>

                                                                   Exhibit 32.2






                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


By signing below, each of the undersigned  officers hereby certifies pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2003,  that,  to his  knowledge,  (i) this  report  fully  complies  with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and (ii) the  information  contained  in this  report  fairly  presents,  in all
material respects, the financial condition and results of operations of Alliance
Health, Inc.

Signed this 12th day of August, 2004.



/s/Sharilyn J. Bruntz Wilson
Sharilyn J. Bruntz Wilson
Vice President and Secretary
Chief Financial Officer